Switzerland· 52776001
Normosang, Konzentrat zur Herstellung einer Infusionslösung
A hemin product, registered in Switzerland by RECORDATI AG and dispensed under Swissmedic category A. The same ATC class is registered in 11 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Hemin is registered in 11 of 19 countries.
Countries holding a registration under ATC B06AB01 (hemin), each read from that country’s own register.
- This record: Switzerland
- 6 of them publish a price we can compare per daily dose
Hemin · ATC B06AB01
11 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
- Manufacturer
- RECORDATI AG
- Country
- Switzerland (CH)
- ATC code
- B06AB01
- ATC class
- Hemin
- Swissmedic category
- A
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
90 interactions on record for hemin.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hemin · interactions on record
90 records
- 21 severe
- 69 moderate
Most severe, free to view
- EstradiolD11AX34severe
- Levonorgestrel and ethinylestradiolG03AA07severe
- Desogestrel and ethinylestradiolG03AA09severe
- Drospirenone and ethinylestradiolG03AA12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B06AB01
Hemin, as other registers publish it.
- FinlandNormosangRecordati Rare Diseases
- NorwayNormosangRecordati Rare Diseases
- DenmarkNormosangRecordati Rare Diseases
- FinlandNormosangOrphan Europe SARL
- CzechiaNORMOSANGRecordati Rare Diseases, Puteaux
- NetherlandsNormosang 25 mg/ml, concentraat voor oplossing voor infusieRecordati Rare Diseases
- IrelandNormosang 25 mg/ml, concentrate for solution for infusionRecordati Rare Diseases
- FranceNORMOSANG 25 mg/ml, solution à diluer pour perfusionRECORDATI RARE DISEASES
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af98c22e-8f63-4e58-91ec-8d564eeab564 GET /v1/drugs/af98c22e-8f63-4e58-91ec-8d564eeab564?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Blutprodukte"
}See everything about hemin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.